Online Mind Mapping and Brainstorming

Create your own awesome maps

Online Mind Mapping and Brainstorming

Even on the go

with our free apps for iPhone, iPad and Android

Get Started

Already have an account? Log In

Uricosuric Drug--Allopurinol by Mind Map: Uricosuric Drug--Allopurinol
0.0 stars - reviews range from 0 to 5

Uricosuric Drug--Allopurinol

Core Patient Variables: Health Status--obtain baseline CBC, uric acid level, liver function tests, and metabolic profile. Document baseline joint stiffness, ROM and patient's pain level. Life Span and Gender--Pregnancy Category C-determine if patient is pregnant or breastfeeding. Adjust dose if elderly. Lifestyle, Diet and Habits--administer drug after meal to decrease potential for N/V. Teach patient to ingest 2.5-3 L of fluid daily to avoid renal calculi.

New node

Pharmacotherapeutics: Chronic gout, recureent calcium renal stones and hyperuricemia r/t to cancer or tumor lysis syndrome. Off-label uses-several=prevention of ischemic reperfusion tissue damage and arrythmias, decrease in H. pylori induced duodenal ulcer recurrence rates, treatment of hematemesis from NSAID induced erosive gastritis.

Pharmacokinetics: Given orally or IV. Orally- ~90% is absorbed. Widely distributed except to CNS. Undergoes hepatic metabolism and rapidly oxidized to oxypurinol=both have renal elimination.

Contraindications and Precautions: Hypersensitivity. Give cautiously to patients who cannot maintain a fluid intake of 2 L/day as in CHF, patients with decreased renal or liver function, patients taking thiazide diurectics or drugs that induce myelosuppression.

Adverse Effects: Generally well-tolerated. Most commonly-pruritus, maculopapular rash, N/V, elevated liver function tests and acute gout symptoms. Serious effects-blood dyscrasias, myelosuppression, hepatic/renal toxicity, exfoliative dermatitis, and Stevens-Johnson syndrome.

Drug Interactions: interacts with many drugs that increase potential for hypersensitivity reaction, interacts with immunosuppressive and cytotoxic drugs (which can cause myelosuppression). To name a few--ampicillin, antacids, azathioprine, captopril, cyclophosphamide, hydantoins, theophylline, thiazide diuretics.

Nursing Management

Maximizing Therapeutic Effects: Administer with colchicine to decrease potential for gout flare-up, initially. Teach patient about meals that decrease uric acid production (limit consumption of meat products and seafood, alcohol and beer; encourage purine-rich vegetables and dairy intake).

Minimizing Adverse Effects: Administer drug after meals to decrease N/V. Encourage fluid intake to 2.5-3 L/day. Teach patient importance of following schedule (start at 100 mg/day, then increase 100 mg at weekly intervals until uric acid level is <6 mg/dL or max dose reached.

Patient and Family Education: Emphasize need to follow dosage instructions; advise about minor adverse effects; advise about notifying health care provider if rash develops; advise that there are serious adverse effects; advise that optimal benefits from therapy may take 2-6 weeks; advise patient to avoid ETOH; advise patient about foods that produce uric acid; encourage 2.5-3 L/day fluid intake; advise on importance of routine follow-up; advise patient to never start or stop allopurinol therapy during an acute flare.